
Monday, September 02, 2024 3:51:45 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent BCDA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2025 01:36:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/27/2025 02:15:22 PM
- BioCardia Announces Late Breaking Clinical Trial Presentation on CardiAMP Heart Failure Trial at the American College of Cardiology 2025 Scientific Sessions • GlobeNewswire Inc. • 01/27/2025 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2024 07:30:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2024 07:30:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/17/2024 04:50:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2024 12:00:13 PM
- BioCardia Announces Commercial Availability of Morph® DNA™ Steerable Introducer Product Family • GlobeNewswire Inc. • 12/17/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2024 10:04:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2024 01:30:21 PM
- BioCardia Announces Positive Consultation with Japan PMDA on CardiAMP Cell Therapy for Ischemic Heart Failure • GlobeNewswire Inc. • 12/04/2024 01:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/02/2024 10:03:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2024 01:00:13 PM
- BioCardia Reports Third Quarter 2024 Business Highlights and Financial Results • GlobeNewswire Inc. • 11/13/2024 09:05:00 PM
- BioCardia to Host Q3 2024 Corporate Update and Financial Results Conference Call on November 13, 2024 • GlobeNewswire Inc. • 11/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/28/2024 01:00:11 PM
- BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure • GlobeNewswire Inc. • 10/28/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2024 01:57:16 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2024 01:56:49 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2024 01:56:24 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2024 01:56:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2024 01:55:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2024 01:55:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2024 01:55:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2024 01:55:15 AM
FEATURED Animoca Brands leads Hivello funding round ahead of Token Listing • Feb 10, 2025 10:20 AM
51 Labs Expands Sports Nutrition Line with Five New Innovative Products, Company in final phase of name and ticker symbol change • CAFI • Feb 10, 2025 9:00 AM
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption • UMAV • Feb 6, 2025 8:30 AM
VAYK Project $700K 2024 Revenue with $150K Net Profit • VAYK • Feb 5, 2025 12:43 PM
UAV Corp (UMAV) Kicks Off Landmark "SKY" Hangar Project with Land Clearing at Costin Airport Setting Stage for Q1 2025 Groundbreaking • UMAV • Feb 5, 2025 8:30 AM
HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future • HLYK • Feb 4, 2025 8:00 AM